It has been suggested that poor the loading ability of ApoE ε4 lipoproteins may lead to deficient β-amyloid clearance and cholesterol trafficking in AD patients, leading to synaptic dysfunction, destruction, and neuronal loss, thereby triggering glia cell activation and inflammatory processes [38,39,40,41,42]. This evidence concerns the gene APOE and Alzheimer disease.